Sudden onset of multiple nevi after administration of 6-mercaptopurine in an adult with Crohn's disease: A case report

International Journal of Dermatology

Volumn 44, Issue 4, 2005, Pages 334-336

  Kakrida, Marilena ^a   Orengo, Ida F ^a   Markus, Ramsey ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; MERCAPTOPURINE; MESALAZINE;

ADULT; ARTICLE; CASE REPORT; CORRELATION ANALYSIS; CROHN DISEASE; DIODE LASER; DRUG WITHDRAWAL; ESTHETICS; FEMALE; HUMAN; MELANOCYTIC NEVUS;

6-MERCAPTOPURINE; ADULT; CROHN DISEASE; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 17444392129     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02086.x     Document Type: Article

References (16)

1. Happle R, Koopman RJ. [Acral nevi following chemotherapy]. Hautarzt 1990; 41: 331-332.
2. Baird EA, McHenry PM, MacKie RM. Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. BMJ 1992; 305: 799-801.
3. Persley K, Scherl E, Rubin P. Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis. Am J Gastroenterol 2001; 96: 3444-3445.
4. Rizzello F, Gionchetti P, Venturi A, et al. The management of refractory Crohn's disease. Aliment Pharmacol Ther 2002; 16 (Suppl. 4): 40-47.
5. Dreizen S, Bodey GP, Rodriquez V, et al. Cutaneous complications of cancer chemotherapy. Postgrad Med 1975; 58: 150-158.
6. Hughes BR, Cunliffe WJ, Bailey CC. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ 1989; 299: 88-91.
7. Jappe U, Abeck D, Janka-Schaub GE, et al. [Induction of multiple melanocytic nevus cell nevi in 2 children with malignant hematologic systemic diseases and chemotherapy-induced immunosuppression]. Hautarzt 1996; 47: 537-540.
8. Szepietowski J, Wasik F, Szepietowski T, et al. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 1997; 194: 17-19.
9. Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) 1986; 292: 1555-1559.
10. Grulich AE, Bataille V, Swerdlow AJ, et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales. Aus Int J Cancer 1996; 67: 485-491.
11. Green A, McCredie M, MacKie R, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999; 10: 11-25.
12. Vibhagool CBH, Grevelink JM. Treatment of small nevomelanocytic nevi with a Q-switched ruby laser. J Am Acad Dermatol 1997; 36: 738-741.
13. Reda AM, Taha IR, Riad HA. Clinical and histological effect of a single treatment of normal mode alexandrite (755 nm) laser on small melanocytic nevi. J Cutan Laser Ther 1999; 1: 209-215.
14. Soden CESK, Smith K, Skelton H. Histologic features seen in changing nevi after therapy with an 810 nm pulsed diode laser for hair removal in patients with dysplastic nevi. Int J Dermatol 2001; 40: 500-504.
15. Hoang MP, Prieto VG, Burchette JL, et al. Recurrent melanocytic nevus: a histologic an dimmunohistochemical evaluation. J Cutan Pathol 2001; 28: 400-406.
16. Hwang K, Lee WJ, Lee SI. Pseudomelanoma after laser therapy. Ann Plast Surg 2002; 48: 562-564.